CLINICAL AND ECONOMIC BENEFITS OF NATIONAL IMMUNIZATION WITH THE 13-VALENT COMPARED TO 7-AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN GREECE

被引：1
|
作者：
Papanicolaou, S.
Kontodimas, S. [1 ]
Syriopoulou, V
Tsolia, M. [2 ]
Theodoridou, M. [2 ]
Strutton, D. R. [3 ]
Hwang, S. [3 ]
Tzanakaki, G. [4 ]
Kremastinou, J. [4 ]
Earnshaw, S. R. [5 ]
Farkouh, R. [5 ]
Karokis, A. [6 ]
Konstantopoulos, A.
机构：
[1] Wyeth Hellas SA, Athens, Attika, Greece
[2] Univ Athens, Sch Med, GR-11527 Athens, Greece
[3] Wyeth Res, Collegeville, PA USA
[4] Natl Sch Publ Hlth, Athens, Greece
[5] RTI Hlth Solut, Res Triangle Pk, NC USA
[6] Wyeth, Athens, Greece
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75093-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A423 / A424
页数：2
相关论文
共 50 条
  • [31] Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context
    Bolanos-Diaz, Rafael
    Mino-Leon, Greta
    Zea, Eduardo
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2022, 13 (04) : 341 - 350
  • [32] Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study
    Vojicic, Jelena
    Grajales, Ana Gabriela
    Cane, Alejandro
    [J]. VACCINE, 2023, 41 (27) : 3949 - 3950
  • [33] Twenty-Year Public Health Impact of 7-and 13-Valent Pneumococcal Conjugate Vaccines in US Children
    Wasserman, Matt
    Chapman, Ruth
    Lapidot, Rotem
    Sutton, Kelly
    Dillon-Murphy, Desmond
    Patel, Shreeya
    Chilson, Erica
    Snow, Vincenza
    Farkouh, Raymond
    Pelton, Stephen
    [J]. EMERGING INFECTIOUS DISEASES, 2021, 27 (06) : 1627 - 1636
  • [34] Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study
    Ricketson, Leah J.
    Bettinger, Julie A.
    Sadarangani, Manish
    Halperin, Scott A.
    Kellner, James D.
    [J]. VACCINE, 2022, 40 (19) : 2733 - 2740
  • [35] Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data
    Feng, Shuo
    McLellan, Julie
    Pidduck, Nicola
    Roberts, Nia
    Higgins, Julian P. T.
    Choi, Yoon
    Izu, Alane
    Jit, Mark
    Madhi, Shabir A.
    Mulholland, Kim
    Pollard, Andrew J.
    Temple, Beth
    Voysey, Merryn
    [J]. ECLINICALMEDICINE, 2023, 61
  • [36] Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults
    Gaillat, J.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (06): : 215 - 221
  • [37] Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines
    Gessner, Bradford D.
    Sings, Heather L.
    Jodar, Luis
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (07): : 692 - 693
  • [38] CLINICAL IMPACT OF REPLACING 13-VALENT WITH A 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN COSTA RICAN NATIONAL IMMUNIZATION PROGRAM
    Rendon, A. M.
    Herrera-Solano, W.
    Hirata, L.
    White, M.
    Huang, M.
    Weaver, J.
    Chhabra, N.
    Singla, P.
    Kumari, S.
    Parellada, C.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S13 - S14
  • [39] The duopoly of ten-valent and 13-valent pneumococcal conjugate vaccines: do they differ?
    Madhi, Shabir A.
    Goldblatt, David
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (05): : 453 - 454
  • [40] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV) Versus 10-Valent PCVs in Filipino Infants
    Perdrizet, J.
    Horn, E.
    Nua, W.
    Perez Peralta, J.
    Nailes, J.
    Santos, J.
    Ong-Lim, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S118 - S118
12345